Methodology & Approach

Indicator Selection Criteria

Assess Relevance

• Pertains to key areas of system performance or outcomes for:
  • 4 most common cancers: breast, prostate, colorectal, lung
  • quality dimensions
• Reflects evidence-based care
• Supports Ontario Cancer Plan priorities, programming or quality improvement initiatives
• Has jurisdictional comparators (not mandatory)

Assess Feasibility

• Data are available and can be obtained with reasonable effort

Assess Timeliness

• Data are less than 3 years old for process indicators and less than 5 years old for outcome indicators

Assess Credibility

• Data are valid, reliable, generalizable, etc.

Prioritize

• Have a jurisdictional comparator
• Report on performance against a quality domain
• Are distinctive and provide a balance of indicators across the cancer care continuum
• No more than 20 indicators per disease site

Indicator Classification Approach

Both statistical significance and clinical interpretations of the performance outcomes inform the classification of indicators.

Indicators with provincial targets

• Meeting or exceeding a provincial target places an indicator into Bright Spot
• Not yet meeting a provincial target, but performing significantly better (statistically, clinically or both) than before, or compared with other jurisdictions, places an indicator into Bright Spot
• Not yet meeting a provincial target, and performing at either the same rate or worse than before places an indicator into Room for Improvement

Indicators without provincial targets

• Performing better (statistically, clinically or both) than before, or compared with other jurisdictions, places an indicator into Bright Spot
• Performing either at the same rate or worse than before places an indicator into Room for Improvement